---
document_datetime: 2023-09-21 19:34:17
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/stocrin-epar-all-authorised-presentations_en.pdf
document_name: stocrin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9319242
conversion_datetime: 2025-12-28 18:05:08.624844
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Content   | Package size   |
|-----------------|-----------------|------------|-----------------------|---------------------------|-----------------------|-----------|----------------|
| EU/1/99/111/005 | Stocrin         | 30 mg/ml   | Oral solution         | Oral use                  | bottle (HDPE)         | 180 ml    | 1 bottle +     |
| EU/1/99/111/008 | Stocrin         | 600 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE)         |           | 30 tablets     |
| EU/1/99/111/010 | Stocrin         | 50 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)         |           | 30 tablets     |
| EU/1/99/111/011 | Stocrin         | 200 mg     | Film-coated tablet    | Oral use                  | bottle (HDPE)         |           | 90 tablets     |